IRVINE, Calif., February 13, 2026 – (BUSINESS WIRE) – Edwards Lifesciences Corporation (NYSE: EW) has exciting news for investors and industry professionals. The company is set to participate in Citi’s Unplugged Medtech and Life Sciences Access Day on February 26, 2026. This event promises to be a significant platform for discussing advancements in the medical technology sector.
The highlight of Edwards Lifesciences’ participation will be a presentation by Scott Ullem, the chief financial officer, scheduled for 10:15 a.m. ET. Attendees can expect valuable insights into the company’s strategic vision and upcoming innovations that are set to redefine the healthcare landscape.
For those unable to attend the live presentation, a webcast will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/. Additionally, an archived version of this presentation will be accessible later that same day, ensuring that all interested parties can benefit from the insights shared.
About Edwards Lifesciences
Edwards Lifesciences stands as a leader in global structural heart innovation, focused on enhancing patient outcomes through advanced medical technology. The company is dedicated to developing groundbreaking solutions aimed at improving the quality of life for patients suffering from heart conditions.
Driven by a passion for patient care, Edwards Lifesciences collaborates with world-class clinicians and healthcare stakeholders. This collaboration fosters the creation of life-saving innovations. The company’s commitment to a patient-focused culture inspires its employees to push the boundaries of what’s possible in medical science.
To learn more about Edwards Lifesciences and its innovative efforts in the medical field, explore the website at www.edwards.com and connect with the company on social platforms like LinkedIn, Facebook, Instagram, and YouTube.
Contact Information
For media inquiries, please reach out to Amy Meshulam at media@edwards.com. Investors seeking more information can contact the investor relations team at investor_relations@edwards.com.
For the original source version of this press release, visit Business Wire.
This rewritten HTML article incorporates relevant headings, keywords, and engages the reader while maintaining informative content about Edwards Lifesciences’ upcoming presentation.
